Treatment provides control of the muscle inflammation and allows the patient to return to normal function; the patient might otherwise become disabled from the weakness. The skin disease is often symptomatic and is cosmetically displeasing, therefore the goal of therapy is to relieve the symptoms and improve the patient's self-image and ability to interact with other people. Some patients with dermatomyositis have an associated malignancy, and treatment of the malignancy might in some patients result in a control of the disease process. In children with dermatomyositis, treatment also aims to prevent calcinosis, or to eradicate calcinosis if it does occur.
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.